CYTO-NK-203

N/A

Report date: 2022/09/06 18:03:55

Base Information

Drug NameCYTO-NK-203
Drug Alias NameCYTO-NK-203
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionImmunologic cytotoxicityNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytoImmune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical CenterCytoImmune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A